These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37991563)

  • 21. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.
    Barrett-Lee P; Casbard A; Abraham J; Hood K; Coleman R; Simmonds P; Timmins H; Wheatley D; Grieve R; Griffiths G; Murray N
    Lancet Oncol; 2014 Jan; 15(1):114-22. PubMed ID: 24332514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-infectious osteomyelitis of the mandible in a young woman: a case report.
    Rasmussen AQ; Andersen UB; Jørgensen NR; Schwarz P
    J Med Case Rep; 2014 Feb; 8():44. PubMed ID: 24521360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
    Grbic JT; Landesberg R; Lin SQ; Mesenbrink P; Reid IR; Leung PC; Casas N; Recknor CP; Hua Y; Delmas PD; Eriksen EF;
    J Am Dent Assoc; 2008 Jan; 139(1):32-40. PubMed ID: 18167382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience.
    Valadares LP; de Araújo Ferreira BS; da Cunha BM; Moreira LA; Batista FGA; da Fonseca Hottz C; Magalhães GGR
    Arch Endocrinol Metab; 2022 Apr; 66(2):247-255. PubMed ID: 35420267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in Treatment of Primary Osteoporotic Vertebral Compression Fractures.
    Huang ZF; Xiao SX; Liu K; Xiong W
    Pain Physician; 2019 Jan; 22(1):63-68. PubMed ID: 30700069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Genetic Features of Chinese Adult Patients With Chronic Non-Bacterial Osteomyelitis: A Single Center Report.
    Zhao M; Wu D; Yu K; Shen M
    Front Immunol; 2022; 13():860646. PubMed ID: 35422809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
    Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX
    Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
    Montella L; Addeo R; Palmieri G; Caraglia M; Cennamo G; Vincenzi B; Guarrasi R; Mamone R; Faiola V; Frega N; Capasso E; Maiorino L; Leopardo D; Pizza C; Montesarchio V; Del Prete S
    Cancer Chemother Pharmacol; 2010 May; 65(6):1137-43. PubMed ID: 19760218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw.
    Yamashita J; Sawa N; Sawa Y; Miyazono S
    Bone; 2021 Feb; 143():115611. PubMed ID: 32829042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
    Raje N; Terpos E; Willenbacher W; Shimizu K; García-Sanz R; Durie B; Legieć W; Krejčí M; Laribi K; Zhu L; Cheng P; Warner D; Roodman GD
    Lancet Oncol; 2018 Mar; 19(3):370-381. PubMed ID: 29429912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis.
    Kostik MM; Kopchak OL; Chikova IA; Isupova EA; Mushkin AY
    Rheumatol Int; 2019 Jan; 39(1):89-96. PubMed ID: 30171342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial.
    Cai G; Aitken D; Laslett LL; Pelletier JP; Martel-Pelletier J; Hill C; March L; Wluka AE; Wang Y; Antony B; Blizzard L; Winzenberg T; Cicuttini F; Jones G
    JAMA; 2020 Apr; 323(15):1456-1466. PubMed ID: 32315057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
    Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
    Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
    Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
    Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis.
    Bozzo A; Deng J; Abbas U; Bhasin R; Deodat M; Wariach S; Sanger S; Axelrod D; Masrouha K; Turcotte R; Wilson D; Ghert M
    Clin Orthop Relat Res; 2021 Sep; 479(9):2047-2057. PubMed ID: 33835092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoledronic acid and clinical fractures and mortality after hip fracture.
    Lyles KW; Colón-Emeric CS; Magaziner JS; Adachi JD; Pieper CF; Mautalen C; Hyldstrup L; Recknor C; Nordsletten L; Moore KA; Lavecchia C; Zhang J; Mesenbrink P; Hodgson PK; Abrams K; Orloff JJ; Horowitz Z; Eriksen EF; Boonen S;
    N Engl J Med; 2007 Nov; 357(18):1799-809. PubMed ID: 17878149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.
    Weinfurt KP; Anstrom KJ; Castel LD; Schulman KA; Saad F
    Ann Oncol; 2006 Jun; 17(6):986-9. PubMed ID: 16533874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis.
    Wilkinson GS; Kuo YF; Freeman JL; Goodwin JS
    J Natl Cancer Inst; 2007 Jul; 99(13):1016-24. PubMed ID: 17596574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.